Human papillomaviruses (HPVs) have been linked to a variety of human diseases, most
notably cancer of the cervix, a disease responsible for at least 200,000 deaths per year …

Genital warts (condyloma acuminata) have been documented since the time of Hippocrates,
and cutaneous warts were reported by the first century AD. It was not until the late eighteenth …

The lack of broad‐spectrum tumor antigens, limited immunogenicity of antigens, and
immunosuppressive microenvironment in tumors have impeded the development of cancer …

Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor
for cervical cancer. Given the substantial disease and death associated with HPV and …

High‑risk human papillomavirus (HPV) is a common cause of cervical cancer. HPV E6
oncoprotein promotes the degradation of host tumor suppressor gene p53, leading to the …

Background The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in
malignant cellular transformation, represents a key antigen for developing therapeutic …

The causal association between papillomavirus (HPV) infection and cervical cancer has
been demonstrated; the development of a prophylactic vaccine to protect against HPV …

High-risk human papillomaviruses are linked to several malignancies including cervical
cancer. Because human papillomavirus-infected women do not always mount protective …

Human papillomavirus (HPV) can cause condyloma acuminatum and cervical cancer. Some
mutations of these viruses are closely related to the persistent infection of cervical cancer …

T-cell based immunotherapy is an attractive approach for the treatment of multiple tumor
types including cervical carcinoma. Immunostimulating DNA containing unmethylated …